Biosimilars Conference 2015

This conference discusses biosimilars in the EU and internationally, with a focus on both regulatory and scientific challenges as well as market access and experiences.

Back to Agenda

Panel Debate: What Will the Future Landscape of Biosimilars Look Like and How Should We Prepare for that?

Session Chair(s)

Steffen Thirstrup, MD, PHD

Chief Medical Officer, European Medicines Agency, Netherlands

Continuing from the previous sessions, the panel discussion will allow a stakeholder debate on status quo and discuss how the governance framework could facilitate better understanding and acceptance of biosimilars challenged by counter-arguments.

Speaker(s)

Paul Cornes, MD

Oncologist, Bristol Oncology Centre, United Kingdom

Biosimilars - the Physicians' Learning Curve

Leon van Aerts, PHD

, Medicines Evaluation Board, The Netherlands, Netherlands

Thijs Giezen, PHARMD, PHD, MSC

, Medicines Evaluation Board, Netherlands

Pekka T Kurki, MD, PHD

Research Professor, Finnish Medicines Agency, Finland

Have an account?